BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38605477)

  • 1. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
    Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
    Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway.
    Chen L; Lin L; Xian N; Zheng Z
    Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
    Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.
    Ouédraogo ZG; Müller-Barthélémy M; Kemeny JL; Dedieu V; Biau J; Khalil T; Raoelfils LI; Granzotto A; Pereira B; Beaudoin C; Guissou IP; Berger M; Morel L; Chautard E; Verrelle P
    Brain Pathol; 2016 Jan; 26(1):18-30. PubMed ID: 25736961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
    Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
    CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHIF promotes glioblastoma progression and radioresistance via exosomes.
    Dai X; Liao K; Zhuang Z; Chen B; Zhou Z; Zhou S; Lin G; Zhang F; Lin Y; Miao Y; Li Z; Huang R; Qiu Y; Lin R
    Int J Oncol; 2019 Jan; 54(1):261-270. PubMed ID: 30387845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
    Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
    J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
    Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
    Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0060055 Promotes the Growth, Invasion, and Radioresistance of Glioblastoma by Targeting MiR-197-3p/API5 Axis.
    Yuan J; Liu Z; Liu J; Fan R
    Neurotox Res; 2022 Oct; 40(5):1292-1303. PubMed ID: 35849320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration.
    Porcù E; Maule F; Manfreda L; Mariotto E; Bresolin S; Cani A; Bortolozzi R; Della Puppa A; Corallo D; Viola G; Rampazzo E; Persano L
    Transl Res; 2023 Jan; 251():41-53. PubMed ID: 35788055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.